REPORTS

Let’s Pullulate and Expand Your Business

In-Vitro Diagnostics Market - Global Professional Analysis and Forecast to 2026

Mar 16, 2020  |  224 PAGES  |  REPORT CODE: CMM272121
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide In-Vitro Diagnostics market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 4.6% during the forecast period.

This report presents the market size and development trends by detailing the In-Vitro Diagnostics market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the In-Vitro Diagnostics market will be shown in this report. In short, this report will comprehensively reveal the characteristics of In-Vitro Diagnostics industry and will help you to build a panoramic view of the industrial development.

In-Vitro Diagnostics Market, By Type:

  • Tissue diagnostics

  • Professional diagnostic

  • Molecular diagnostic

  • Diabetes Monitoring

In-Vitro Diagnostics Market, By Application:

  • Diabetes Monitoring

  • Diabetes Monitoring

  • Diabetes Monitoring

  • Diabetes Monitoring

  • Diabetes Monitoring

  • Diabetes Monitoring

  • Diabetes Monitoring

Some of the leading players are as follows:

  • Mindray

  • Cobas

  • Johnson and Johnson

  • Beckman Coulter Inc

  • Ortho Clinical Diagnostics

  • Abbott Laboratories

  • Aptiv Solution

  • Siemens Healthcare

  • Danaher Corporation

  • Beijing Leadman Biochemistry

  • Shanghai Kehua Bio-engineering

  • BioSino Bio-technology

  • DAAN Gene

  • Becton Dickinson

  • Biomerieux

  • Roche Diagnostics

  • Thermo Scientific

  • Bio-Rad Laboratories

  • Merck Millipore

  • Sysmex Corporation

  • Caprion

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 In-Vitro Diagnostics Market: Technology Type Analysis

  • 4.1 In-Vitro Diagnostics Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 In-Vitro Diagnostics Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Tissue diagnostics

    • 4.3.2 Professional diagnostic

    • 4.3.3 Molecular diagnostic

    • 4.3.4 Diabetes Monitoring

5 In-Vitro Diagnostics Market: Product Analysis

  • 5.1 In-Vitro Diagnostics Product Market Share Analysis, 2018 & 2026

  • 5.2 In-Vitro Diagnostics Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 In-Vitro Diagnostics Market: Application Analysis

  • 6.1 In-Vitro Diagnostics Application Market Share Analysis, 2018 & 2026

  • 6.2 In-Vitro Diagnostics Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Diabetes Monitoring

    • 6.3.2 Diabetes Monitoring

    • 6.3.3 Diabetes Monitoring

    • 6.3.4 Diabetes Monitoring

    • 6.3.5 Diabetes Monitoring

    • 6.3.6 Diabetes Monitoring

    • 6.3.7 Diabetes Monitoring

7 In-Vitro Diagnostics Market: Regional Analysis

  • 7.1 In-Vitro Diagnostics Regional Market Share Analysis, 2018 & 2026

  • 7.2 In-Vitro Diagnostics Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Mindray

    • 9.1.1 Mindray Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Cobas

    • 9.2.1 Cobas Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Johnson and Johnson

    • 9.3.1 Johnson and Johnson Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Beckman Coulter Inc

    • 9.4.1 Beckman Coulter Inc Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Ortho Clinical Diagnostics

    • 9.5.1 Ortho Clinical Diagnostics Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Abbott Laboratories

    • 9.6.1 Abbott Laboratories Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Aptiv Solution

    • 9.7.1 Aptiv Solution Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Siemens Healthcare

    • 9.8.1 Siemens Healthcare Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Danaher Corporation

    • 9.9.1 Danaher Corporation Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Beijing Leadman Biochemistry

    • 9.10.1 Beijing Leadman Biochemistry Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Shanghai Kehua Bio-engineering

    • 9.11.1 Shanghai Kehua Bio-engineering Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 BioSino Bio-technology

    • 9.12.1 BioSino Bio-technology Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 DAAN Gene

    • 9.13.1 DAAN Gene Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Becton Dickinson

    • 9.14.1 Becton Dickinson Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Biomerieux

    • 9.15.1 Biomerieux Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Roche Diagnostics

    • 9.16.1 Roche Diagnostics Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 Thermo Scientific

    • 9.17.1 Thermo Scientific Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Bio-Rad Laboratories

    • 9.18.1 Bio-Rad Laboratories Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 Merck Millipore

    • 9.19.1 Merck Millipore Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Sysmex Corporation

    • 9.20.1 Sysmex Corporation Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Caprion

    • 9.21.1 Caprion Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

 

The List of Tables and Figures (Totals 80 Figures and 154 Tables)

  • Figure Tissue diagnostics In-Vitro Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Professional diagnostic In-Vitro Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Molecular diagnostic In-Vitro Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring In-Vitro Diagnostics market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring market, 2015 - 2026 (USD Million)

  • Figure Diabetes Monitoring market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America In-Vitro Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table North America In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table North America In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table North America In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table U.S. In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table U.S. In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Canada In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Canada In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Europe In-Vitro Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Europe In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Europe In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Europe In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table U.K. In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table U.K. In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Germany In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Germany In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table France In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table France In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Italy In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Italy In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Spain In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Spain In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific In-Vitro Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table China In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table China In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Japan In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Japan In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table India In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table India In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Latin America In-Vitro Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table Latin America In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Latin America In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Latin America In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Brazil In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Brazil In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Mexico In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Mexico In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Argentina In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Argentina In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table MEA In-Vitro Diagnostics market, by country, 2015 - 2026 (USD Million)

  • Table MEA In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table MEA In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table MEA In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table South Africa In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table South Africa In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria In-Vitro Diagnostics market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria In-Vitro Diagnostics market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria In-Vitro Diagnostics market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Mindray Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Cobas Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Johnson and Johnson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beckman Coulter Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ortho Clinical Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Abbott Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Aptiv Solution Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Siemens Healthcare Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Danaher Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beijing Leadman Biochemistry Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Shanghai Kehua Bio-engineering Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BioSino Bio-technology Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DAAN Gene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Becton Dickinson Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biomerieux Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Roche Diagnostics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Thermo Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bio-Rad Laboratories Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Millipore Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sysmex Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Caprion Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top